CNE000001K65
CNE000001K65
YIFAN PHARM
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 11.75B EUR | 11.37B EUR | 15.42B EUR |
Enterprise Value | 11.44B EUR | 12.96B EUR | 17.05B EUR |
Valuation Multiples | |||
Trailing P/E | 38.64x | 30.76x | 36.32x |
Forward P/E | 15.84x | -- | -- |
Price to Sales | 2.37x | 2.28x | 3.02x |
Price to Book | 1.13x | 1.29x | 1.73x |
EV/Revenue | 2.3x | 2.6x | 3.34x |
EV/EBITDA | 16.8x | 24.16x | 29.15x |
Price to FCF (P/FCF) | 301.61x | 60.19x | 136.63x |
EV/FCF | 293.57x | 68.57x | 151.02x |
FCF Yield | 0.33% | 1.66% | 0.73% |